It’s estimated that cardiovascular diseases, including those of the blood vessels supplying the heart muscle and the brain, are the leading cause of death globally.

With the incidence of cardiovascular disease going through the roof, Kalorama Information’s report, World Market for Cardiac Markers (POC and Lab-Based), covers why cardiac markers are in huge demand and a constant subject of research for improvement.

Cardiac biomarkers are substances that are released into the bloodstream when the heart is damaged or stressed. In patients with chronic heart failure, measurement of these biomarkers is used to help risk stratify, to assess treatment options, and monitor progress.